| P2093 | author name string | Simon M Cool | |
| | Victor Nurcombe | |
| | Sadasivam Murali | |
| | Denise F M Leong | |
| | Jaslyn J L Lee | |
| P2860 | cites work | Characterization of cells with osteogenic potential from human marrow | Q68117980 |
| | Endothelial heparan sulphate: compositional analysis and comparison of chains from different proteoglycan populations | Q68407274 |
| | Heparinase II from Flavobacterium heparinum. Action on chemically modified heparins | Q70146621 |
| | Evidence for a (1 leads to 4)-linked 4-O-( -L-idopyranosyluronic acid 2-sulfate)-(2-deoxy-2-sulfoamino-D-glucopyranosyl 6-sulfate) sequence in heparin. Long-range H-H coupling in 4-deoxy-hex-4-enopyranosides | Q70681538 |
| | Quantitative assessment of FGF regulation by cell surface heparan sulfates | Q75362239 |
| | The enzymic degradation of heparitin sulfate | Q79060346 |
| | Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species | Q24530061 |
| | Adult bone marrow stromal cells differentiate into neural cells in vitro | Q28142055 |
| | The enzymatic degradation of heparin and heparitin sulfate. 3. Purification of a heparitinase and a heparinase from flavobacteria | Q28253221 |
| | Regulated diversity of heparan sulfate | Q28282444 |
| | Heparan sulfate mediates the proliferation and differentiation of rat mesenchymal stem cells | Q28580650 |
| | Order out of chaos: assembly of ligand binding sites in heparan sulfate | Q29620085 |
| | Mass spectrometric evidence for the enzymatic mechanism of the depolymerization of heparin-like glycosaminoglycans by heparinase II. | Q32000531 |
| | Heparan sulfate domain organization and sulfation modulate FGF-induced cell signaling | Q33615579 |
| | Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery | Q34012747 |
| | Isolation and characterization of heparan sulfate from various murine tissues | Q34074853 |
| | Molecular diversity of heparan sulfate | Q34310374 |
| | Examination of the substrate specificity of heparin and heparan sulfate lyases | Q34324156 |
| | Specificity studies on the heparin lyases from Flavobacterium heparinum | Q34352372 |
| | Structure and biological interactions of heparin and heparan sulfate | Q34523315 |
| | Mesenchymal stem cells and their potential as cardiac therapeutics | Q35830869 |
| | Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects | Q36184145 |
| | Organ-specific heparan sulfate structural phenotypes. | Q37169432 |
| | The structure of glycosaminoglycans and their interactions with proteins. | Q37353143 |
| | Pluripotent plasticity of stem cells and liver repopulation | Q37709980 |
| | Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes | Q38294596 |
| | Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor. | Q38312077 |
| | Elucidation of the structural features of heparan sulfate important for interaction with the Hep-2 domain of fibronectin. | Q38315553 |
| | Cooperative dimerization of fibroblast growth factor 1 (FGF1) upon a single heparin saccharide may drive the formation of 2:2:1 FGF1.FGFR2c.heparin ternary complexes | Q38320039 |
| | Heparinase II from Flavobacterium heparinum. HPLC analysis of the saccharides generated from chemically modified heparins | Q38331863 |
| | Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development | Q38339362 |
| | Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2. | Q40218083 |
| | Monomer complexes of basic fibroblast growth factor and heparan sulfate oligosaccharides are the minimal functional unit for cell activation | Q40957417 |
| | Sequence analysis of heparan sulphate indicates defined location of N-sulphated glucosamine and iduronate 2-sulphate residues proximal to the protein-linkage region | Q41777711 |
| | Molecular organization of heparan sulphate from human skin fibroblasts | Q41975008 |
| | Distribution of iduronate 2-sulphate residues in heparan sulphate. Evidence for an ordered polymeric structure | Q42161980 |
| | Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development | Q43124071 |
| | Purification and characterization of heparin lyases from Flavobacterium heparinum | Q43893111 |
| | Distinct substrate specificities of bacterial heparinases against N-unsubstituted glucosamine residues in heparan sulfate | Q45261009 |
| | The effect of heparin on osteoblast differentiation and activity in primary cultures of bovine aortic smooth muscle cells | Q45273950 |
| | Characterizing the non-reducing end structure of heparan sulfate | Q46633551 |
| | An improved graph cut segmentation method for cervical lymph nodes on sonograms and its relationship with node's shape assessment. | Q51812465 |
| | Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. | Q52196589 |
| | Developmental Regulation of Neural Response to FGF-1 and FGF-2 by Heparan Sulfate Proteoglycan | Q52225676 |
| | Purification and substrate specificity of heparitinase I and heparitinase II from Flavobacterium heparinum. Analyses of the heparin and heparan sulfate degradation products by 13C NMR spectroscopy. | Q54313822 |
| | Liver heparan sulfate structure. A novel molecular design | Q64146700 |
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| P304 | page(s) | 17755-17765 | |
| P577 | publication date | 2011-03-25 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Comparative assessment of the effects of gender-specific heparan sulfates on mesenchymal stem cells | |
| P478 | volume | 286 | |